Adverse Events Mild, Rare With mAb Treatment for COVID-19 in Pregnancy
TUESDAY, Nov. 15, 2022 (HealthDay News) — For pregnant persons with COVID-19, adverse events after monoclonal antibody (mAb) treatment are mild and occur rarely, according to a study published online Nov. 15 in the Annals of Internal Medicine.Erin K….
Learn MoreSARS-CoV-2 Reinfection Ups Risks for Death, Hospitalization
TUESDAY, Nov. 15, 2022 (HealthDay News) — Reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with increased risks for death, hospitalization, and sequelae in the acute and postacute phases, according to a stud…
Learn MoreModerna Booster Shot Prompts Strong Immune Response Against Omicron Subvariants
MONDAY, Nov. 14, 2022 (HealthDay News) — Moderna announced Monday that its updated booster shot triggers strong antibody responses against three omicron subvariants.”We are pleased to see that both of our bivalent booster vaccine candidates offer sup…
Learn MoreLa vacuna contra la COVID ofrece a las embarazadas y sus bebés una mejor protección que la infección previa
JUEVES, 10 de noviembre de 2022 (HealthDay News) — Vacunarse contra la COVID-19 durante el embarazo provee unos niveles más altos de anticuerpos tanto a la mamá como al bebé que contraer el virus, encuentra un estudio reciente.Cuando las mujeres emba…
Learn MoreLa listeria en fiambres y quesos ha provocado 13 casos de enfermedad y 1 muerte
JUEVES, 10 de noviembre de 2022 (HealthDay News) — Las autoridades de salud pública están investigando un brote de listeria que ha infectado a personas en al menos seis estados, ha hospitalizado a 13, acabó con la vida de una y provocó la pérdida de …
Learn MoreModerna’s Booster Shot Prompts Strong Immune Response Against Omicron Subvariants
MONDAY, Nov. 14, 2022 (HealthDay News) — Moderna, Inc., announced Monday that its updated booster shot triggers strong antibody responses against three Omicron subvariants.”We are pleased to see that both of our bivalent booster vaccine candidates of…
Learn MoreBepirovirsen Studied for Treatment of Chronic Hepatitis B Infection
MONDAY, Nov. 14, 2022 (HealthDay News) — A 300-mg dose of bepirovirsen per week for 24 weeks results in sustained hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA loss in 9 to 10 percent of patients with chronic HBV infection, acco…
Learn MoreNew Health Problems Post-COVID-19 Also Seen in Children, Teens
MONDAY, Nov. 14, 2022 (HealthDay News) — Similar to adults, children and adolescents who have previously had COVID-19 also are at risk for post-COVID-19 syndrome, and the most common symptoms may differ by age group, according to a study published on…
Learn MoreDoes Your Child Have a Cold or Severe RSV? Signs to Look For
MONDAY, Nov. 14, 2022 (HealthDay News) — As most American parents already know, cases of respiratory syncytial virus (RSV), a common illness of childhood, are surging this year. Hospitals are filling up with babies and toddlers very ill with the easy…
Learn MoreDamage to Health Mounts With Each New COVID Infection
MONDAY, Nov. 14, 2022 (HealthDay News) — Every time a person gets infected with COVID-19, their risk of dying or suffering serious long-term health problems increases dramatically, a new study has found.People with repeated COVID-19 infections are tw…
Learn More